EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief

Shriya Karmarkar, Trinette Fernandes, Zainab Choonia, Sankalp Gharat, Sujata Sawarkar

RSC Pharmaceutics · 2025 · 2 (1) · 19-43

DOI: 10.1039/d4pm00133h ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Shriya Karmarkar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ligand-based nanotechnology is promising in enhancing targeted drug delivery in autoimmune disorders. This study explores molecular targets and new active targeting techniques. These technologies enhance drug specificity via precise targeting.

Zitieren

APA

Karmarkar, S., Fernandes, T., Choonia, Z., Gharat, S., & Sawarkar, S. (2025). Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief. RSC Pharmaceutics, 2(1), 19-43. https://doi.org/10.1039/d4pm00133h

Vancouver

Karmarkar S, Fernandes T, Choonia Z, Gharat S, Sawarkar S. Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief. RSC Pharmaceutics. 2025;2(1):19-43. doi:10.1039/d4pm00133h

BibTeX
@article{Karmarkar2025,
  author = {Karmarkar, Shriya and Fernandes, Trinette and Choonia, Zainab and Gharat, Sankalp and Sawarkar, Sujata},
  title = {Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief},
  journal = {RSC Pharmaceutics},
  year = {2025},
  volume = {2},
  number = {1},
  pages = {19--43},
  doi = {10.1039/d4pm00133h}
}
Kostenlos starten →